Muscle-Invasive Bladder Carcinoma

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer

Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach

Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation

ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy

Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers

Prophylactic Antibiotics in Cystectomy With Diversion

Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)

NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment

A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study

Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma